These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 31533883

  • 1. Metformin and tuberculosis risk in elderly patients with diabetes mellitus.
    Park S, Yang BR, Song HJ, Jang SH, Kang DY, Park BJ.
    Int J Tuberc Lung Dis; 2019 Aug 01; 23(8):924-930. PubMed ID: 31533883
    [Abstract] [Full Text] [Related]

  • 2. The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus.
    Heo E, Kim E, Jang EJ, Lee CH.
    BMC Pulm Med; 2021 Sep 25; 21(1):303. PubMed ID: 34563159
    [Abstract] [Full Text] [Related]

  • 3. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment.
    Pan SW, Yen YF, Kou YR, Chuang PH, Su VY, Feng JY, Chan YJ, Su WJ.
    Chest; 2018 Jun 25; 153(6):1347-1357. PubMed ID: 29253553
    [Abstract] [Full Text] [Related]

  • 4. Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study.
    Lee MC, Lee CH, Lee MR, Wang JY, Chen SM.
    BMC Infect Dis; 2019 Nov 06; 19(1):936. PubMed ID: 31694558
    [Abstract] [Full Text] [Related]

  • 5. Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes.
    Lin SY, Tu HP, Lu PL, Chen TC, Wang WH, Chong IW, Chen YH.
    Respirology; 2018 Nov 06; 23(11):1063-1073. PubMed ID: 29943489
    [Abstract] [Full Text] [Related]

  • 6. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH.
    Diabetes Metab Res Rev; 2015 Sep 06; 31(6):619-26. PubMed ID: 25820555
    [Abstract] [Full Text] [Related]

  • 7. Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study.
    Wahlqvist ML, Lee MS, Chuang SY, Hsu CC, Tsai HN, Yu SH, Chang HY.
    BMC Med; 2012 Nov 29; 10():150. PubMed ID: 23194378
    [Abstract] [Full Text] [Related]

  • 8. Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.
    Inzucchi SE, Tunceli K, Qiu Y, Rajpathak S, Brodovicz KG, Engel SS, Mavros P, Radican L, Brudi P, Li Z, Fan CP, Hanna B, Tang J, Blonde L.
    Diabetes Obes Metab; 2015 Oct 29; 17(10):956-64. PubMed ID: 25962401
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.
    Lee MC, Chiang CY, Lee CH, Ho CM, Chang CH, Wang JY, Chen SM.
    PLoS One; 2018 Oct 29; 13(10):e0205807. PubMed ID: 30335800
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia.
    Yu O, Azoulay L, Yin H, Filion KB, Suissa S.
    Am J Med; 2018 Mar 29; 131(3):317.e11-317.e22. PubMed ID: 29032229
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.
    Ou SM, Shih CJ, Chao PW, Chu H, Kuo SC, Lee YJ, Wang SJ, Yang CY, Lin CC, Chen TJ, Tarng DC, Li SY, Chen YT.
    Ann Intern Med; 2015 Nov 03; 163(9):663-72. PubMed ID: 26457538
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus.
    Tseng CH.
    Biomolecules; 2021 Sep 25; 11(10):. PubMed ID: 34680039
    [Abstract] [Full Text] [Related]

  • 20. Association Between Metformin Initiation and Incident Dementia Among African American and White Veterans Health Administration Patients.
    Scherrer JF, Morley JE, Salas J, Floyd JS, Farr SA, Dublin S.
    Ann Fam Med; 2019 Jul 25; 17(4):352-362. PubMed ID: 31285213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.